Kairos Pharma, Ltd. (AMEX: KAPA) last traded at $0.829, down 0.36% on the session. The quote above updates while this page is open; the figures below are drawn from Kairos Pharma, Ltd.’s own filings and are restated only when a new one is published.
Kairos Pharma, Ltd. trades on AMEX under the ticker KAPA. Its market capitalisation is $19.65 million.
Valuation measures for Kairos Pharma, Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $19.65M |
|---|---|
| Enterprise value | $17.28M |
| Price / book | 4.69 |
| Beta | 1.64 |
Trailing-twelve-month figures tagged in Kairos Pharma, Ltd.'s XBRL filings with the SEC.
| Net income (TTM) | -$5.80M |
|---|
| EPS (TTM) | -$0.280 |
|---|
| Return on equity | -138.51% |
|---|
| Cash | $2.63M |
|---|
Range and volume for KAPA over the past 52 weeks.
| 52-week high | $9.17 |
|---|---|
| 52-week low | $0.740 |
| Volume | 155.2K |
| Average volume | 610.0K |
| Previous close | $0.832 |
Invest a chosen dollar amount in Kairos Pharma, Ltd. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KAPA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.